Juvenile granulosa cell tumor with massive ascites: A case report and immunohistochemical study of ascites formation

Juvenile granulosa cell tumors (JGCTs) are rare tumors, representing 5% of all granulosa cell tumors (GCTs) that occurs in premenarchal girls and young women. Clinical signs in Juvenile granulosa cell tumor after adolescence are menstrual irregularities or amenorrhea in most cases. We describe here a rare case of 23-year-old nulliparous woman with Juvenile granulosa cell tumor, whose only clinical manifestation was abdominal distention due to massive ascites. The patient underwent mass resection with salpingo-oophorectomy. No metastatic implants were noted in the peritoneal cavity, and cytology of ascitic fluid was negative for malignancy. Immunohistochemically, the staining for vascular endothelial growth factor (VEGF) was observed diffusely in the cytoplasm of tumor cells and partly in the endothelial cells, together with marked tumor microvessel density visualized by staining with blood endothelial marker CD34. These results suggest that vascular endothelial growth factor-driven angiogenesis and increased vascular permeability in Juvenile granulosa cell tumor may cause massive ascites production from the tumor itself.

Juvenile granulosa cell tumor (JGCT); massive ascites; vascular endothelial growth factor (VEGF).

[1] Plantaz D., Flamant F., Vassal G., Chappuis J.P., Baranzelli M.C., Bouffet E.: “Granulosa cell tumors of the ovary in children and ado-lescents. Multicenter retrospective study in 40 patients aged 7 months to 22 years”. Arch. Fr. Pediatr., 1992, 49, 793.

[2] Young R.H., Dickersin G.R., Scully R.E.: “Juvenile granulosa cell tumor of the ovary. A clinicopathological analysis of 125 cases”. Am. J. Surg. Pathol., 1984, 8, 575.

[3] Lee I.H., Choi C.H., Hong D.G., Song J.Y., Kim Y.J., Kim K.T.: “Clinicopathologic characteristics of granulosa cell tumors of the ovary: a multicenter retrospective study”. J. Gynecol. Oncol., 2011, 22, 188.

[4] Ranganath R., Sridevi V., Shirley S.S., Shantha V.: “Clinical and pathologic prognostic factors in adult granulose cell tumors of the ovary”. Int. J. Gynecol. Cancer, 2008, 18, 929.

[5] Miyoshi A., Miyatake T., Hara T., Tanaka A., Komura N., Komiya S., et al.: “Etiology of ascites and pleural effusion associated with ovar-ian tumors: literature review and case reports of three ovarian tu-mors presenting with massive ascites, but without peritoneal dissemination”. Case Rep. Obstet. Gynecol., 2015, 2015, 414019.

[6] Rubinstein Y., Dashkovsky I., Cozacov C., Hadary A., Zidan J.: “Pseudo Meigs’ syndrome secondary to colorectal adenocarcinoma metastasis to the ovaries”. J. Clin. Oncol., 2009, 27, 1334.

[7] Färkkilä A., Anttonen M., Pociuviene J., Leminen A., Butzow R., Heikinheimo M., et al.: “Vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 are highly expressed in ovarian granulosa cell tumors”. Eur. J. Endocrinol., 2011, 164, 115.

[8] Bishop C.V., Lee D.M., Slayden O.D., Li X.: “Intravenous neutralization of vascular endothelial growth factor reduces vascular function/permeability of the ovary and prevents development of OHSSlike symptoms in rhesus monkeys”. J. Ovarian Res., 2017, 10, 41.